Loss of FCHSD1 leads to amelioration of chronic obstructive pulmonary disease.

MLA

Takahiro Kawasaki, et al. “Loss of FCHSD1 Leads to Amelioration of Chronic Obstructive Pulmonary Disease.” Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 26, June 2021, pp. 1–8. EBSCOhost, https://doi.org/10.1073/pnas.2019167118.

APA

Takahiro Kawasaki, Fuminori Sugihara, Kiyoharu Fukushima, Takanori Matsuki, Hiroshi Nabeshima, Tomohisa Machida, Yuichi Mitsui, Saki Fujimura, Rio Sagawa, Lee Gaheun, Kanako Kuniyoshi, Hiroki Tanaka, Masashi Narazaki, Atsushi Kumanogoh, Shizuo Akira, & Takashi Satoh. (2021). Loss of FCHSD1 leads to amelioration of chronic obstructive pulmonary disease. Proceedings of the National Academy of Sciences of the United States of America, 118(26), 1–8. https://doi.org/10.1073/pnas.2019167118

Chicago

Takahiro Kawasaki, Fuminori Sugihara, Kiyoharu Fukushima, Takanori Matsuki, Hiroshi Nabeshima, Tomohisa Machida, Yuichi Mitsui, et al. 2021. “Loss of FCHSD1 Leads to Amelioration of Chronic Obstructive Pulmonary Disease.” Proceedings of the National Academy of Sciences of the United States of America 118 (26): 1–8. doi:10.1073/pnas.2019167118.